Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 10, keine Gesamtzahl für „concomitant“
Suchtreffer
Begriffe & Kennungen
Cabazitaxel Accord · 4.5 · Concomitant administration of aprepitant, a moderate CYP3A inhibitor, had no effect on cabazitaxel clearance.
Eintrag öffnenCalquence · 4.5 · Concomitant use with strong CYP3A/P-gp inhibitors should be avoided. If the strong CYP3A/P-gp inhibitors (e.g.
Eintrag öffnenCalquence · 4.5 · Concomitant use with strong CYP3A/P-gp inhibitors should be avoided. If the strong CYP3A/P-gp inhibitors (e.g.
Eintrag öffnenCalquence · 4.5 · Concomitant use with strong inducers of CYP3A activity (e.g., phenytoin, rifampicin, carbamazepine) should be
Eintrag öffnenCalquence · 4.5 · Concomitant use with strong inducers of CYP3A activity (e.g., phenytoin, rifampicin, carbamazepine) should be
Eintrag öffnenCamzyos · 4.5 · 10 Table 2: Dose modification/monitoring of mavacamten with concomitant medicinal products
Eintrag öffnenCamzyos · 4.5 · 11 Concomitant CYP2C19 poor metaboliser phenotype* CYP2C19 intermediate, medicinal product normal, rapid and u
Eintrag öffnenCamzyos · 4.5 · 12 Concomitant CYP2C19 poor metaboliser phenotype* CYP2C19 intermediate, medicinal product normal, rapid and u
Eintrag öffnenCamzyos · 4.5 · Concomitant CYP2C19 poor metaboliser phenotype* CYP2C19 intermediate, medicinal product normal, rapid and ultr
Eintrag öffnenCatiolanze · 4.5 · There have been reports of paradoxical elevations in IOP following the concomitant ophthalmic administration o
Eintrag öffnenCellCept · 4.5 · 29 Telmisartan Concomitant administration of telmisartan and mycophenolate mofetil resulted in an approximatel
Eintrag öffnenCellCept · 4.5 · 73 Rifampicin In patients not also taking ciclosporin, concomitant administration of mycophenolate mofetil and
Eintrag öffnenCellCept · 4.5 · 8 In patients not also taking ciclosporin, concomitant administration of mycophenolate mofetil and rifampicin
Eintrag öffnenCellCept · 4.5 · Concomitant administration of drugs affecting glucuronidation of MPA may change MPA exposure. Caution is there
Eintrag öffnenCellCept · 4.5 · Concomitant administration of drugs affecting glucuronidation of MPA may change MPA exposure. Caution is there
Eintrag öffnenCellCept · 4.5 · Concomitant administration of drugs affecting glucuronidation of MPA may change MPA exposure. Caution is there
Eintrag öffnenCellCept · 4.5 · Concomitant administration of drugs affecting glucuronidation of MPA may change MPA exposure. Caution is there
Eintrag öffnenCellCept · 4.5 · Isavuconazole An increase of MPA exposure (AUC0-∞) by 35% was observed with concomitant administration of isav
Eintrag öffnenCellCept · 4.5 · Isavuconazole An increase of MPA exposure (AUC0-∞) by 35% was observed with concomitant administration of isav
Eintrag öffnenCellCept · 4.5 · Isavuconazole An increase of MPA exposure (AUC0-∞) by 35% was observed with concomitant administration of isav
Eintrag öffnen